Search Results for: IntraCellular Therapies Announces Enrollment of
Articles
November 21, 2019
Biogen Announces Enrollment Completion of Global Phase 3 Gene Therapy Study November 21, 2019
Biogen Inc. recently announced the enrollment of the last patient in the global Phase 3 STAR clinical study, which is...
October 9, 2017
Intra-Cellular Therapies Announces Enrollment of Clinical Trial October 9, 2017
Intra-Cellular Therapies, Inc. recently announced the company has commenced enrollment in the ITI-214-105 Phase 1/2 clinical trial in patients with...
July 6, 2017
Cytokinetics Announces Baseline Data From First Cohort of Phase 2 Clinical Trial July 6, 2017
Cytokinetics, Inc. recently announced that data relating to patient baseline characteristics and the reasons for patient screen failure, both from...
April 12, 2016
Adaptimmune Announces FDA Acceptance of IND Application April 12, 2016
Adaptimmune Therapeutics plc recently announced that the US FDA has accepted the company’s investigational new drug (IND) application for autologous...
April 4, 2016
Rexahn Pharmaceuticals Announces Initiation of Phase Ib/IIa Clinical Trial of Novel Oral Anti-Cancer Therapeutic April 4, 2016
Rexahn Pharmaceuticals, Inc. recently announced that is has enrolled the first patient in its Phase Ib/IIa clinical trial of a...
January 12, 2016
Cytokinetics Announces Start of Phase II Clinical Trial January 12, 2016
Cytokinetics, Inc. recently announced that its first Phase II clinical trial of CK-2127107, a novel fast skeletal muscle troponin activator,...
